IQN Path and the International Society for Immunohistochemistry and Molecular Morphology (ISIMM) have put together a 4-part series on Quality Assurance for Clinical Immunohistochemistry. “Evolution of Quality Assurance for Clinical Immunohistochemistry (IHC) in the Era of Precision Medicine” from the lead author Emina Torlakovic. – Part 1: Fit-for-purpose Approach to Classification of Clinical IHC Biomarkers – read more…
Category Archives: IHC
Successful meeting of the In-Situ Methods Working Group
On Sunday 25th September, IQN Path held another successful working group meeting of the In-Situ Methods Working Group. Prof Mogens Vyberg and Dr Emina Torlakovic gave excellent presentations on the challenges and importance of quality in immunohistochemistry (IHC) testing with presentations on positive and negative controls for IHC and an overview of the key concepts read more…
IQN Path teams up with LMP pathologist to standardize immunohistochemistry terminology
IQN Path, represented by the executive director, Dr Jacqueline Hall, has been in collaboration with Dr. Emina Torlakovic Laboratory Medicine Program (LMP) and Canadian Immunohistochemsitry Quality Control (CIQC) an External Quality Assessment (EQA) provider to standardize a terminology and framework for quality in immunohistochemistry (IHC). Dr. Emina Torlakovic, hematopathologist, immunohistochemistry lab director at LMP and read more…
Satellite Workshop to the ECP 2015 – Belgrade, 7th September, 2015
Immunohistochemistry (IHC) is a widely used and well established method, however, there are many considerations to take into account to achieve quality IHC testing. IQN Path is running a multi-stakeholder workshop of key opinion leaders to have an open discussion on what can be done collectively to improve quality in this area and how to read more…